Chimera Investment CorporationCIMNYSE
LOADING
|||

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
15 analysts·Moderate coverage
20%
Rating Distribution
Strong Buy
00%
Buy
320%
Hold
960%
Sell
320%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 16% higher.

Bear Case
$13.00
+5%
Consensus
$14.25
+16%
Bull Case
$15.50
+26%
Price Range15 analysts
Low
Consensus
High
$13.00
$15.50
Current Target
Current Price
$12.33
Upside to Target
$1.92

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Dec 9, 2025RBC Capital
Chimera downgraded to Sector Perform from Outperform at RBC Capital
Target:$13.00
+1.3%from $12.83
Nov 18, 2025UBS
Chimera price target lowered to $15.50 from $16 at UBS
Target:$15.50
+30.6%from $11.87
Jun 23, 2023Credit Suisse
Check Out 3 High-Yielding Dividend Stocks In Financial Sector From Wall Street's Most Accurate Analysts
Target:$5.50
-0.2%from $5.51
Jul 17, 2022Barclays
Chimera price target lowered to $9 from $11 at Barclays
Target:$9.00
-1.2%from $9.11
Apr 27, 2022Barclays
Barclays Maintains Underweight on Chimera Investment, Lowers Price Target to $11
Target:$11.00
+11.9%from $9.83